Heparin infusion compounding (if commercial product unavailable)

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org

3 posts / 0 new
Last post
Laura Frantz
Laura Frantz's picture
Last seen: 2 days 23 hours ago
Joined: 03/01/2021 - 15:58
Heparin infusion compounding (if commercial product unavailable)

Good afternoon!
Commercial heparin 25,000 units/ 250 mL (100 units/mL) infusion bags are provided as total volume of 250 mL. When intermittent shortages of commercial heparin infusion bags occur, my organization batch compounds bags in the IV room. Preparing these bags as Total Volume” of 250 mL is less efficient for IV room staff (as 5 mL of 1/2 NaCl or D5W volume must be removed from the bags). Med Safety has been asked if it is ok to switch to additive volume (using 5,000 un/mL vials for a total volume of 255 mL instead of 250 mL (would result in 2% lower heparin concentration). As heparin is a high alert infusion, we are concerned about this if a level is not routinely assessed following change to bag with slightly different concentration.

Question: Do any of you prepare heparin as additive volume with 5,000 unit/mL vials? If so, do you have process in place to ensure that a PTT or anti-Xa level is assessed 6 hours after converting between commercial bag vs. IV room compounded bag?

Thank you!